Moreover, METTL3 inhibited expression of AKT protein in BMSCs by mediating m6A RNA methylation of AKT1, thus reducing MSC adipogenesis and alleviating chemoresistance in AML cells (Pan et al., 2021). The gene discussed is AKT1; the disease is acute myeloid leukemia.